In a cohort of 8,162 breast/ovarian cancer families from the German Consortium for Hereditary Breast and Ovarian Cancer, eight female DH patients for BRCA1 and BRCA2 mutations were described and analyzed for their phenotypic features (22). The gene discussed is BRCA2; the disease is ovarian carcinoma.